메뉴 건너뛰기




Volumn 370, Issue 22, 2014, Pages 2142-2143

A new hope for idiopathic pulmonary fibrosis

Author keywords

[No Author keywords available]

Indexed keywords

NINTEDANIB; PIRFENIDONE; PLACEBO;

EID: 84901789150     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1403448     Document Type: Editorial
Times cited : (48)

References (13)
  • 1
    • 77951176799 scopus 로고    scopus 로고
    • Idiopathic pulmonary fibrosis: A disease with similarities and links to cancer biology
    • Vancheri C, Failla M, Crimi N, Raghu G. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J 2010;35:496-504.
    • (2010) Eur Respir J , vol.35 , pp. 496-504
    • Vancheri, C.1    Failla, M.2    Crimi, N.3    Raghu, G.4
  • 2
    • 79956341531 scopus 로고    scopus 로고
    • Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): Two randomised trials
    • Noble PW, Albera C, Bradford WZ, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 2011;377:1760-9.
    • (2011) Lancet , vol.377 , pp. 1760-1769
    • Noble, P.W.1    Albera, C.2    Bradford, W.Z.3
  • 3
    • 84901810710 scopus 로고    scopus 로고
    • Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
    • Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2071-82.
    • (2014) N Engl J Med , vol.370 , pp. 2071-2082
    • Richeldi, L.1    Du Bois, R.M.2    Raghu, G.3
  • 4
    • 84901759236 scopus 로고    scopus 로고
    • A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis
    • King TE Jr, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2083-92.
    • (2014) N Engl J Med , vol.370 , pp. 2083-2092
    • King Jr., T.E.1    Bradford, W.Z.2    Castro-Bernardini, S.3
  • 5
    • 80053091084 scopus 로고    scopus 로고
    • Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis
    • Richeldi L, Costabel U, Selman M, et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 2011;365:1079-87.
    • (2011) N Engl J Med , vol.365 , pp. 1079-1087
    • Richeldi, L.1    Costabel, U.2    Selman, M.3
  • 7
    • 0347996179 scopus 로고    scopus 로고
    • Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity
    • DOI 10.1034/j.1600-6143.2002.020201.x
    • Shihab FS, Bennett WM, Yi H, Andoh TF. Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity. Am J Transplant 2002;2:111-9. (Pubitemid 36306789)
    • (2002) American Journal of Transplantation , vol.2 , Issue.2 , pp. 111-119
    • Shihab, F.S.1    Bennett, W.M.2    Yi, H.3    Andoh, T.F.4
  • 10
    • 84861394764 scopus 로고    scopus 로고
    • Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis
    • The Idiopathic Pulmonary Fibrosis Clinical Research Network
    • The Idiopathic Pulmonary Fibrosis Clinical Research Network. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012;366:1968-77.
    • (2012) N Engl J Med , vol.366 , pp. 1968-1977
  • 11
    • 84901746607 scopus 로고    scopus 로고
    • Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis
    • The Idiopathic Pulmonary Fibrosis Clinical Research Network
    • The Idiopathic Pulmonary Fibrosis Clinical Research Network. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2093-101.
    • (2014) N Engl J Med , vol.370 , pp. 2093-2101


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.